Effect of 50% ethanolic extract of roots of Cissampelos pareira on some bio-chemical parameters to investigate the hepato-protective study in animal model (Rats)
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2016, Vol 5, Issue 6
Abstract
In phytotherapeutic approach, the emphasis is on the development of a new drug whose extraction and fractionation have emanated on the basis of therapeutic activity. Cissampelos pareira Linn. (C. microcarpa, De Candolle) is a very variable, lofty, slender, dioecious, perennial, climber commonly distributed throughout topical and sub topical India, ascending up to an altitude of c 2,000m. The plant is very common in orchards, hedges, parks and gardens on moist soils, either creeping or twining around other plants. The roots of Cissampelos pareira (L.) Hirsuta (Menispermaceae) were collected and extracted with 50% ethanol solution. The selected plant extract was subjected for the preliminary acute toxicity studies in mice at different dose levels up to 2000 mg/kg. The results showed no abnormal symptoms either p.o or i.p and cause no mortality. Before the actual LD50 determination, a pilot study was made on a small group of mice mainly to select the dose ranges for the subsequent study. The 50% ethanolic extract of Cissampelos pareira were taken at various dose levels (200, 500, 1000, 1500, 2000 mg/kg b.wt.) dissolved in 1 % carboxymethyl cellulose administered orally to pairs of mice per dose level. The value of probability less than 5% (P < 0.05) was considered statically significant. Histological architecture of the C. pariera treated liver samples showed the ability of the C. papeira to prevent hepatocellular necrosis. In conclusion, the antitubercular drugs (isoniazid and rifampicin)-induced alterations on protein metabolism and hepatic antioxidant defense system were normalized by Cissampelos pareira co-administration, indicating a possible cytoprotective role of Cissampelos pareira against drug induced hepatotoxicity. Thus our studies give scientific evidences to support this plant’s traditional uses as claimed in folklore medicine. It was concluded from the results that the alcoholic extract of Cissampelos pareira (L.) possesses hepato-protective effect in experimental animals Key words: Cissampelos pareira Linn, C. pariera, dioecious
Authors and Affiliations
Vinay Kumar
Keywords
Related Articles
- EP ID EP418073
- DOI -
- Views 140
- Downloads 0
FORMULATIONS AND EVALUATION OF FILM COATED IMMEDIATE RELEASE TABLETS OF PIRACETAM
An immediate release dosage form allows a manufacturer to extend market exclusivity, 100 mg of Piracetam was accurately weighed and transferred to previously dried 100 ml volumetric flask. Drug was dissolved in 0.01N sod...
Association between Psychological Status and Dyspnea in Patients with Chronic Obstructive Pulmonary Disease
Background: Dyspnea together with anxiety and depression are the most common and important comorbidities in patients with chronic obstructive pulmonary disease. Anxiety and depression can potentiate the intensity of dysp...
KCNQ potassium channel expression in the caprine ureter and inhibition ofthecontractility of isolated distal caprine ureter by KCNQ channel opener Retigabine
Voltage gated potassium channels i.eKCNQ potassium channels are expressed in several types of smooth muscles and may possibly mediate physiological responses in the tissues where they are expressed. Flupirtineand Retigab...
COLLECTION, PURIFICATION AND PHYTOCHEMICAL SCREENING OF A NATURAL GUM FOR ORAL CONTROLLED DRUG DELIVERY SYSTEM
Present study highlighted that sustained release matrix tablet of Indomethacin using gum karaya (GK) as matrix former. Various concentrations of KG used to ensure the release model. Preformulation study of Indomethacin w...
DRUG USE PATTERN IN MANAGEMENT OF RESPIRATORY EMERGENCIES IN MICU-A PROSPECTIVE OBSERVATIONAL STUDY
BACKGROUND: Drug utilization studies are useful tool to facilitate rational prescribing of drugs. The objective of the study is to analyze drug utilization in respiratory emergencies using WHO Prescribing Indicators, in...